SOLICITATION NOTICE
H -- cDNA Microarray Analysis of Osteosarcoma Tumors
- Notice Date
- 7/22/2003
- Notice Type
- Solicitation Notice
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- Reference-Number-NCI-30088-NV
- Response Due
- 7/29/2003
- Archive Date
- 8/13/2003
- Point of Contact
- Deborah Moore, Purchasing Agent, Phone (301) 402-4509, Fax (301) 402-4513, - Renita Smith, Contract Specialist, Phone 301-496-8612, Fax 301-480-0241,
- E-Mail Address
-
dm170b@nih.gov, rs442i@nih.gov
- Description
- The National Cancer Institute (NCI), Center for Cancer Research (CCR), Pediatric Oncology Branch (POB) plans to procure on a sole source basis with the Rizzoli Institute of Orthopedic Research (RIOR), Bologna, Italy for the continued cDNA microarry analysis of osteosarcoma tumor samples.The Pediatric Oncology Branch: 1) conducts clinical and laboratory investigations on the biology and treatment of common malignancies which occur in young patients, including acute leukemia, non-Hodgkin?s lymphomas (especially Burkitt?s tumor), neuroblastoma, osteogenic sarcoma, rhabdomyosarcoma, and Ewing?s sarcoma; 2) conducts clinical trials which combine aggressive chemotherapy with immunotherapy using tumor specific translocations and cellular immune reconstitution; 3) performs clinical studies of Phase I and II agents in pediatric tumors; and 4) conducts laboratory and clinical studies on the pathogenesis and treatment of infectious complications of children with cancer. The POB and the RIOR have been in collaboration for years in the study of osteosarcoma and is now attempting to link patterns of RNA expression to various prognostic features including time to progression and disease-free survival. RIOR owns the samples and is the only Institute known to the researcher that has sufficient numbers of patient samples treated uniformly to conduct this microarry analysis. RIOR is the only source known to the NCI researcher that can provide this data and samples with out the introduction of new variables into ongoing research. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.5 to use simplified procedures for commercial acquisitions. This is not a solicitation for competitive quotations. However, if any interested party believes it can provide the above service, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. An original and one copy of the capability statements must be received in the contracting office by 1:00 p.m. EDT, on July 29, 2003. All questions must be in writing and can be faxed to (301) 402-4513 or emailed to dm170b@nih.gov . It is the vendor's responsibility to call (301) 402-4509 to insure questions have been received. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. NAICS 541380.
- Record
- SN00377306-W 20030724/030722213321 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |